Skip to main content

Table 2 ALOX5AP, LTA4H and LTB4R SNPs and COPD susceptibility in smokers.

From: The role of ALOX5AP, LTA4H and LTB4R polymorphisms in determining baseline lung function and COPD susceptibility in UK smokers

SNP

Location

Controls (n = 176)

   

COPD (n = 599)

    

Additive

 
  

0

1

2

MAF

0

1

2

MAF

p-value

Odds ratio

95%CI

ALOX5AP

            

SG13S25 (G/A)

5'UTR

138

35

2

0.11

491

100

5

0.09

0.556

0.87

0.55-1.37

SG13S114 (T/A)

Intron 1

92

63

20

0.29

248

282

58

0.34

0.198

1.22

0.90-1.65

rs3803277 (C/A)

Intron 2

54

80

42

0.47

184

303

103

0.43

0.318

0.87

0.65-1.15

SG13S89 (G/A)

Intron 3

162

13

0

0.04

551

45

1

0.04

0.771

0.90

0.43-1.88

rs4468448 (C/T)

Intron 4

100

65

11

0.25

333

226

34

0.25

0.807

1.04

0.76-1.45

SG13S32 (C/A)

Intron 4

42

88

43

0.49

162

302

130

0.47

0.351

0.87

0.66-1.16

SG13S41 (A/G)

Intron 4

149

21

0

0.06

524

62

6

0.06

0.542

0.84

0.47-1.48

SG13S35 (G/A)

3'UTR

146

26

0

0.06

479

97

3

0.09

0.970

1.01

0.60-1.71

LTA4H

            

rs1978331 (T/C)

Intron 11

66

81

27

0.39

223

257

109

0.40

0.419

0.89

0.68-1.18

rs17677715 (T/C)

Intron 6

115

50

6

0.18

372

188

26

0.20

0.899

1.02

0.72-1.46

rs2660899 (G/T)

5'UTR

130

45

1

0.13

418

158

16

0.16

0.113

1.39

0.93-2.08

rs2540482 (T/C)

5'UTR

107

58

8

0.21

358

195

34

0.23

0.473

1.13

0.81-1.58

rs2660845 (A/G)

5'UTR

92

71

12

0.26

328

224

40

0.26

0.483

0.89

0.65-1.22

rs2540475 (C/T)

5'UTR

108

55

5

0.19

358

186

27

0.21

0.770

0.95

0.67-1.35

LTB4R2

            

rs2332320 (T/C)

5'UTR

130

34

5

0.13

440

124

13

0.13

0.977

1.01

0.67-1.52

rs11158635 (G/T)

5'UTR

100

57

9

0.23

367

193

26

0.21

0.165

0.78

0.55-1.11

rs2516564 (C/T)

5'UTR

104

59

9

0.22

372

193

25

0.21

0.169

0.79

0.56-1.11

LTB4R1

            

rs2224122 (C/G)

5'UTR

102

55

9

0.22

363

190

28

0.21

0.232

0.81

0.57-1.15

rs1046587 (G/A)

3'UTR

43

94

36

0.48

155

298

128

0.48

0.566

1.09

0.82-1.45

rs3181384 (C/T)

3'UTR

100

58

10

0.20

363

191

28

0.21

0.111

0.76

0.54-1.07

  1. Logistic regression was used to compare genotype frequencies between smoking controls (n = 176) and total COPD cases (n = 599) using the additive model with the covariates age, gender and pack-years. OR, odds ratio; 95% CI, 95% confidence interval. 0, 1 and 2 represent the number of major homozygote, heterozygote and minor homozygote genotype frequencies.